MedTrace Logo

Polypharmacy-related Adverse Events in Critically Ill Children

NCT03293927 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2019-07-18

No results posted yet for this study

Summary

The purpose of this study is to learn how 2 medications (fentanyl and dexmedetomidine) affect how sick children think and interact with their environments.

Conditions

  • Delirium

Interventions

DRUG

Fentanyl

The patient will receive IV fentanyl

DRUG

Dexmedetomidine

The patient will receive IV dexemedetomidine

Sponsors & Collaborators

Principal Investigators

  • Kanecia Zimmerman, MD · Duke

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-09
Primary Completion
2019-07-01
Completion
2019-07-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03293927 on ClinicalTrials.gov